◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Dawnrays Pharmaceutical (Holdings) Limited (2348) Financial History

Name: Dawnrays Pharmaceutical (Holdings) Limited (2348) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Dawnrays Pharmaceutical (Holdings) Limited (2348) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 1,081 employees. Its market capitalization is roughly CNY 1 billion. In the fiscal year ended 2025-12-31, 2348 reported CNY 1.2B in revenue and CNY 214M in net income.

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs.

Interactive charts & full statements →

2348 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 1.2B	CNY 1.1B	CNY 1.2B	CNY 1.3B	—
Gross Profit	CNY 612M	CNY 578M	CNY 642M	CNY 774M	—
Operating Income (EBIT)	CNY 302M	CNY 368M	CNY 442M	CNY 448M	—
Net Income	CNY 214M	CNY 565M	CNY 326M	CNY 358M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2348 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 133M)	(CNY 111M)	(CNY 117M)	(CNY 100M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2348 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 4.0B	CNY 4.0B	CNY 3.6B	CNY 3.7B	—
Total Liabilities	CNY 624M	CNY 683M	CNY 763M	CNY 1.0B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2348 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

TRLV · Trulieve Cannabis Corp. — $2 billion
ETON · Eton Pharmaceuticals, Inc. — $2 billion
2161 · JBM (Healthcare) Limited — $2 billion
HROW · Harrow, Inc. — $2 billion
PPGN · PolyPeptide Group AG — $1 billion
1061 · Essex Bio-Technology Limited — $1 billion
PAHC · Phibro Animal Health Corporation — $1 billion
ALVO · Alvotech — $1 billion

← 2347 All “0-9” companies 2349 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.